|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
|
4.10 DÉP., DIAG. & PRONO. - POUMON
|
|
|
Screenings for lung cancer can point to other smoking-related conditions [UPI]
|
|
|
|
|
|
"Only 2 percent of smokers who have lung cancer screenings are going to be found to have actual cancer," Elizabeth Regan, a researcher at National Jewish Health and study lead author, told UPI. "We are providing evidence that you can use those same scans without much of change in expense and be able to identify emphysema, evidence of heart disease and osteoporosis."
|
|
|
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
4.5 DÉP., DIAG. & PRONO. - COLORECTAL
|
|
|
Fewer women do bowel screening test [University of Glasgow]
|
|
|
|
|
|
A research team led by Professor Colin McCowan at the University of St Andrews and Dr Katie Robb from the University of Glasgow found that while 81% of women took part in cervical cancer screening and 73% in breast cancer screening only 60% of women took part in bowel screening.
|
|
|
|
|
|
|
4.7 DÉP., DIAG. & PRONO. - COL DE L'UTÉRUS
|
|
|
|
5. TRAITEMENTS
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
Using MicroRNA to Starve a Tumor? [NIH Director's Blog]
|
|
|
|
|
|
Their studies in mice showed that loss of TGF-beta signals in endothelial cells blocked the growth of new blood vessels and thus tumors. Further study showed that those effects were due in part to elevated levels of miR-30c. The two interact in endothelial cells as part of a previously unrecognized signaling pathway that coordinates the growth of new blood vessels in tumors.
|
|
|
|
|
|
|
5.12 IMMUNOTHÉRAPIES
|
|
|
|
5.12.4 IMMUNOTHÉRAPIES - ESSAIS
|
|
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
|
5.2 PHARMA
|
|
|
|
|
5.2.1 PHARMA - PARTENARIATS
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
6.1 OBSERVATION
|
|
|
PTSD linked to increased risk of ovarian cancer [Harvard]
|
|
|
|
|
|
To better understand how PTSD may influence ovarian cancer risk, researchers analyzed data from the Nurses’ Health Study II, which tracked the health of tens of thousands of women between 1989 and 2015 through biennial questionnaires and medical records. Participants were asked about ovarian cancer diagnosis on each questionnaire, and information was validated through a review of medical records.
|
|
|
|
|
|
|